Original Source(s)
Related Content
FDA Expands Marstacimab Indication in Hemophilia A and B
Phase 3 BASIS and BASIS KIDS data supported the expanded indication across pediatric and inhibitor-pretreated populations.
June 8, 2026
-
3 min
FDA Clears Olastrocel Trial Expansion
Additional patients with ongoing opioid use are being enrolled as Creative Medical prepares for potential Phase 3 discussions with the FDA.
June 22, 2026
-
3 min
FDA Approves First Therapy to Reduce Pancreatitis Risk
In two placebo-controlled trials, triglyceride levels declined by up to 72% compared with placebo.
June 24, 2026
-
2 min